Evidence map›Paper›PMID 30664740›Full record

ArticleNature structural & molecular biology2019

Xist RNA antagonizes the SWI/SNF chromatin remodeler BRG1 on the inactive X chromosome.

Teddy Jégu, Roy Blum, Jesse C Cochrane, Lin Yang, Chen-Yu Wang, Maud-Emmanuelle Gilles, David Colognori, Attila Szanto, Sharon K Marr, Robert E Kingston and 1 more

Abstract read
In one paragraph

Article in Nature structural & molecular biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Plumbing mysterious RNAs in "dark genome" for the conquest of human diseases.Molecular therapy : the journal of the American Society of Gene Therapy · 2023
    Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Teddy JéguHoward Hughes Medical Institute, Boston, MA, USA.
Roy BlumHoward Hughes Medical Institute, Boston, MA, USA.
Jesse C CochraneDepartment of Molecular Biology, Massachusetts General Hospital, Boston, MA, USA.
Lin YangHoward Hughes Medical Institute, Boston, MA, USA.
Chen-Yu WangHoward Hughes Medical Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0002-3912-5113
Maud-Emmanuelle GillesInstitute for RNA Medicine, Department of Pathology, Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
David ColognoriHoward Hughes Medical Institute, Boston, MA, USA.
Attila SzantoHoward Hughes Medical Institute, Boston, MA, USA.
Sharon K MarrDepartment of Molecular Biology, Massachusetts General Hospital, Boston, MA, USA.
Robert E KingstonDepartment of Molecular Biology, Massachusetts General Hospital, Boston, MA, USA.
Jeannie T LeeHoward Hughes Medical Institute, Boston, MA, USA. lee@molbio.mgh.harvard.edu.ORCID http://orcid.org/0000-0001-7786-8850
Howard Hughes Medical Institute · USHarvard University · USBeth Israel Deaconess Medical Center · US

Funding

Transcription Factor Interactions with NucleosomesR37GM048405 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI KINGSTON, ROBERT · 2009 to 2018
$3.9M
TRANSCRIPTION FACTOR INTERACTIONS WITH NUCLEOSOMESR01GM048405 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI KINGSTON, ROBERT · 1993 to 2008
$3.1M
The RNA-activation platform to treat X-linked disease in a locus-specific manner.R01DA036895 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI LEE, JEANNIE T · 2013 to 2017
$1.7M
NIDA NIH HHS R01 DA036895NIGMS NIH HHS R01 GM048405NIGMS NIH HHS R37 GM048405
6 · The paper itself

Abstract

The noncoding RNA Xist recruits silencing factors to the inactive X chromosome (Xi) and facilitates re-organization of Xi structure. Here, we examine the mouse epigenomic landscape of Xi and assess how Xist alters chromatin accessibility. Xist deletion triggers a gain of accessibility of select chromatin regions that is regulated by BRG1, an ATPase subunit of the SWI/SNF chromatin-remodeling complex. In vitro, RNA binding inhibits nucleosome-remodeling and ATPase activities of BRG1, while in cell culture Xist directly interacts with BRG1 and expels BRG1 from the Xi. Xist ablation leads to a selective return of BRG1 in cis, starting from pre-existing BRG1 sites that are free of Xist. BRG1 re-association correlates with cohesin binding and restoration of topologically associated domains (TADs) and results in the formation of de novo Xi 'superloops'. Thus, Xist binding inhibits BRG1's nucleosome-remodeling activity and results in expulsion of the SWI/SNF complex from the Xi.

Indexed as

Adenosine TriphosphatasesAnimalsCell LineChromatinChromosomal Proteins, Non-HistoneEpigenesis, GeneticFemaleMiceNucleosomesRNA, Long NoncodingRNA, UntranslatedX ChromosomeAdenosine TriphosphatasesChromatinChromosomal Proteins, Non-HistoneNucleosomesRNA, Long NoncodingRNA, UntranslatedXIST non-coding RNA

Identifiers

PMID30664740
PMCPMC6421574
OpenAlexW2909477895

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.